Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Ronan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|February 4, 2025
An open window: the crucial role of the gut-brain axis in neurodevelopmental outcomes post-neurocritical illnessVictoria Ronan
Gastroenterology|December 11, 2020
Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood DevelopmentVictoria Ronan, Rummanu Yeasin, Erika C Claud
Neurobiology of Disease|October 28, 2006
Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotectionRachel Karlnoski, Donna Wilcock, Chad Dickey, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 9, 2008
Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic miceRachel A Karlnoski, Arnon Rosenthal, Jennifer Alamed, et al.
Journal of Neuroinflammation|May 12, 2006
Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic miceNiki C Carty, Donna M Wilcock, Arnon Rosenthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 19, 2006
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic miceDonna M Wilcock, Jennifer Alamed, Paul E Gottschall, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|February 4, 2025
An open window: the crucial role of the gut-brain axis in neurodevelopmental outcomes post-neurocritical illnessVictoria Ronan
Gastroenterology|December 11, 2020
Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood DevelopmentVictoria Ronan, Rummanu Yeasin, Erika C Claud
Neurobiology of Disease|October 28, 2006
Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotectionRachel Karlnoski, Donna Wilcock, Chad Dickey, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 9, 2008
Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic miceRachel A Karlnoski, Arnon Rosenthal, Jennifer Alamed, et al.
Journal of Neuroinflammation|May 12, 2006
Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic miceNiki C Carty, Donna M Wilcock, Arnon Rosenthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 19, 2006
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic miceDonna M Wilcock, Jennifer Alamed, Paul E Gottschall, et al.
Pageof 1